{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:21:57Z","timestamp":1788495717582,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jss.2020.07.026","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T05:27:40Z","timestamp":1598333260000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Multidisciplinary Management of Angiosarcoma \u2013 A Review"],"prefix":"10.1016","volume":"257","author":[{"given":"Emily C.","family":"Sturm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5994-4119","authenticated-orcid":false,"given":"Isabella S.","family":"Marasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2020.07.026_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.anndiagpath.2010.07.012","article-title":"Cutaneous angiosarcoma. Analysis of 434 cases from the surveillance, epidemiology, and end results program, 1973-2007","volume":"15","author":"Albores-Saavedra","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.jss.2020.07.026_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hed.21513","article-title":"Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp","volume":"33","author":"Guadagnolo","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.jss.2020.07.026_bib3","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/cncr.11667","article-title":"Cutaneous angiosarcoma of the scalp: a multidisciplinary approach","volume":"98","author":"Pawlik","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jcms.2014.05.002","article-title":"Prognostic features in angiosarcoma of the head and neck: a retrospective monocenter study","volume":"42","author":"Dettenborn","year":"2014","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.jss.2020.07.026_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/01.pas.0000156664.04955.83","article-title":"Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases","volume":"29","author":"Brenn","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jss.2020.07.026_bib6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0360-3016(01)02799-7","article-title":"Sarcoma as a second malignancy after treatment for breast cancer","volume":"52","author":"Yap","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jss.2020.07.026_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2353\/ajpath.2010.090637","article-title":"MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema","volume":"176","author":"Manner","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jss.2020.07.026_bib8","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1002\/cncr.24462","article-title":"Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival","volume":"115","author":"Mery","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1097-0142(194805)1:1<64::AID-CNCR2820010105>3.0.CO;2-W","article-title":"Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica","volume":"1","author":"Stewart","year":"1948","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib10","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/j.jaad.2013.03.011","article-title":"Angiosarcoma in patients with xeroderma pigmentosum: less aggressive and not so rare?","volume":"69","author":"Karkouche","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jss.2020.07.026_bib11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jso.21516","article-title":"Angiosarcoma developing in a non-functioning arteriovenous fistula post-renal transplant","volume":"101","author":"Qureshi","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jclinpath-2017-204601","article-title":"Cutaneous angiosarcoma: a current update","volume":"70","author":"Shustef","year":"2017","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jss.2020.07.026_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ejso.2015.04.022","article-title":"Primary hepatic angiosarcoma","volume":"41","author":"Chaudhary","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaad.2019.07.024","article-title":"Incidence and outcomes of cutaneous angiosarcoma: a SEER population-based study","volume":"83","author":"Conic","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jss.2020.07.026_bib15","doi-asserted-by":"crossref","first-page":"798403","DOI":"10.1155\/2013\/798403","article-title":"Sporadic versus radiation-associated angiosarcoma: a comparative clinicopathologic and molecular analysis of 48 cases","volume":"2013","author":"Hung","year":"2013","journal-title":"Sarcoma"},{"key":"10.1016\/j.jss.2020.07.026_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jaad.2003.10.671","article-title":"Cutaneous angiosarcoma: a case series with prognostic correlation","volume":"50","author":"Morgan","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jss.2020.07.026_bib17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.2921","article-title":"Recurrent PTPRB and PLCG1 mutations in angiosarcoma","volume":"46","author":"Behjati","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jss.2020.07.026_bib18","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/0008-5472.CAN-09-2068","article-title":"KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors","volume":"69","author":"Antonescu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.jss.2020.07.026_bib19","doi-asserted-by":"crossref","first-page":"36041","DOI":"10.18632\/oncotarget.5936","article-title":"Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway","volume":"6","author":"Murali","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2020.07.026_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pathol.2016.08.007","article-title":"MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience","volume":"48","author":"Udager","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.jss.2020.07.026_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.breast.2019.02.011","article-title":"Secondary breast angiosarcoma: a multicentre retrospective survey by the National Italian Association of Breast Surgeons (ANISC)","volume":"45","author":"Taffurelli","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.jss.2020.07.026_bib22","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/01.pas.0000126055.33916.0b","article-title":"Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases","volume":"28","author":"Billings","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jss.2020.07.026_bib23","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0190-9622(03)00428-6","article-title":"Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast","volume":"49","author":"Rao","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jss.2020.07.026_bib24","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1093\/annonc\/mdm381","article-title":"Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases","volume":"18","author":"Fayette","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2000\/575781","article-title":"Confirmed angiosarcoma: prognostic factors and outcome in 50 prospectively followed patients","volume":"4","author":"Espat","year":"2000","journal-title":"Sarcoma"},{"key":"10.1016\/j.jss.2020.07.026_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejca.2012.08.016","article-title":"Localised angiosarcomas: the identification of prognostic factors and analysis of treatment impact. A retrospective analysis from the French Sarcoma Group (GSF\/GETO)","volume":"49","author":"Lindet","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib27","doi-asserted-by":"crossref","first-page":"e26627","DOI":"10.1002\/pbc.26627","article-title":"Clinical case series of pediatric hepatic angiosarcoma","volume":"64","author":"Grassia","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib28","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.suronc.2018.07.010","article-title":"The importance of surgery in scalp angiosarcomas","volume":"27","author":"Cassidy","year":"2018","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoto.2014.3584","article-title":"Angiosarcoma of the scalp and face: the Mayo Clinic experience","volume":"141","author":"Patel","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jss.2020.07.026_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jso.24352","article-title":"A prognostic model for resectable soft tissue and cutaneous angiosarcoma","volume":"114","author":"Sinnamon","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0035-1547520","article-title":"Angiosarcoma of the head and neck","volume":"19","author":"Mullins","year":"2015","journal-title":"Int Arch Otorhinolaryngol"},{"key":"10.1016\/j.jss.2020.07.026_bib32","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/PAS.0b013e318176dbc7","article-title":"Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic","volume":"32","author":"Nascimento","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jss.2020.07.026_bib33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00130404-200505000-00011","article-title":"A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy","volume":"11","author":"Fury","year":"2005","journal-title":"Cancer J"},{"key":"10.1016\/j.jss.2020.07.026_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/PAS.0b013e3180f633a3","article-title":"Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases","volume":"32","author":"Deyrup","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jss.2020.07.026_bib35","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1245\/s10434-006-9335-y","article-title":"Treatment and outcome of 82 patients with angiosarcoma","volume":"14","author":"Abraham","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hed.24554","article-title":"Predisposing factors for poor prognosis of angiosarcoma of the scalp and face: systematic review and meta-analysis","volume":"39","author":"Shin","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.jss.2020.07.026_bib37","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/bjd.13110","article-title":"Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study","volume":"171","author":"Fujisawa","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jss.2020.07.026_bib38","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.ejca.2014.10.004","article-title":"First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials","volume":"50","author":"Young","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib39","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1200\/JCO.2008.17.3146","article-title":"Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study","volume":"26","author":"Penel","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib40","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.0.CO;2-P","article-title":"Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face","volume":"86","author":"Fata","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib41","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2008.07.037","article-title":"Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group","volume":"44","author":"Schlemmer","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib42","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/annonc\/mdr138","article-title":"Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome","volume":"23","author":"Penel","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib43","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1002\/cncr.26599","article-title":"Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas","volume":"118","author":"Italiano","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib44","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2008.21.0088","article-title":"Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules","volume":"27","author":"Demetri","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib45","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ejca.2015.01.006","article-title":"Trabectedin in patients with advanced soft tissue sarcoma: a retrospective national analysis of the French Sarcoma Group","volume":"51","author":"Le Cesne","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib46","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2008.20.4495","article-title":"Phase II study of sorafenib in patients with metastatic or recurrent sarcomas","volume":"27","author":"Maki","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/0284186X.2016.1234068","article-title":"Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis","volume":"56","author":"Kollar","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ebiom.2016.02.026","article-title":"Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a Bench to Bedside study","volume":"6","author":"Pasquier","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jss.2020.07.026_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib50","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1200\/JCO.2015.60.8505","article-title":"Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: a randomized phase II trial","volume":"33","author":"Ray-Coquard","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2020.07.026_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40425-017-0301-y","article-title":"Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials","volume":"5","author":"Groisberg","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s40425-019-0689-7","article-title":"Angiosarcoma patients treated with immune checkpoint inhibitors: a case series of seven patients from a single institution","volume":"7","author":"Florou","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40425-017-0263-0","article-title":"Angiosarcoma treated successfully with anti-PD-1 therapy - a case report","volume":"5","author":"Sindhu","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib54","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2017.07.023","article-title":"Isolated limb perfusion for locally advanced angiosarcoma in extremities: a multi-centre study","volume":"85","author":"Huis In 't Veld","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2020.07.026_bib55","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.crad.2009.02.019","article-title":"Primary hepatic angiosarcoma: imaging findings and palliative treatment with transcatheter arterial chemoembolization or embolization","volume":"64","author":"Park","year":"2009","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jss.2020.07.026_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2214\/AJR.16.17573","article-title":"Safety and efficacy outcomes of embolization in hepatic sarcomas","volume":"210","author":"Pierce","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jss.2020.07.026_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1148\/radiol.2472062029","article-title":"Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival","volume":"247","author":"Sato","year":"2008","journal-title":"Radiology"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420304832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420304832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:51:44Z","timestamp":1758379904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480420304832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":57,"alternative-id":["S0022480420304832"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2020.07.026","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary Management of Angiosarcoma \u2013 A Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2020.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}